Skip to main content
Log in

Calcium Channel Blockers Inhibit the Hyperglycemic Effect of Calcitonin

  • Physiology
  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

We studied the effect of Russian preparation of porcine calcitonin (calcitrin, 1 U/100 g) and blockers of Ca2+ channels nifedipine (1 mg/kg, blocker of chemosensitive Ca2+ channels) and isoptin (5 mg/kg, blocker of voltage-dependent Ca2+ channels) on glucose metabolism. Calcitonin produced a pronounced hyperglycemic effect in rats. A close negative correlation was found between glucose level and total calcium content. Injection of calcitonin reduced glucose tolerance in rats. Isoptin and nifedipine reduced plasma calcium level and did not affect significantly the blood glucose levels, did not change the pattern of alimentary hyperglycemia in response to glucose load, completely abolished the hyperglycemic effect of calcitonin, and prevented calcitonin-induced impairment of glucose tolerance.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. S. S. Butakova and A. D. Nozdrachev, Byull. Eksp. Biol. Med., 147, No. 8, 133-137 (2009).

    Google Scholar 

  2. S. S. Butakova and A. D. Nozdrachev, Vestn. SpbU, Ser. 3, Issue 2, 64-70 (2009).

    Google Scholar 

  3. S. S. Butakova and A. D. Nozdrachev, Uspekhi Gerontol., 23, No.1, 93-97 (2010).

    CAS  Google Scholar 

  4. N. N. Vasilyeva, V. P. Lupanov, and V. G. Naumov, Kardiologiya, No. 4, 15-18 (2000).

  5. N. V. Ivanov, Arterialnaya Gipertenziya, 11, No. 1, 34-38 (2005).

    Google Scholar 

  6. V. B. Mychka, V. V. Gornostaeva, R. M. Bogieva, and I. E. Chazova, Consilium medicum. Arterialnaya gipertoniya, 1, No. 3, Suppl., 25-31 (2001).

  7. L. I. Selochnik, A. I. Briskin, and E. E. Antonova, Khim. Farm. Zh., 12, No. 10, 138-140 (1978).

    CAS  Google Scholar 

  8. N. A. Feldsherova and E. N. Semernin, Kachestvennaya Klinicheskaya Praktika, No. 2, 27-33 (2002).

  9. I. E. Chazova and V. B. Mychka, Metabolic Syndrome [in Russian], Moscow (2004).

  10. R. L. Byyny, M. LoVerde, S. Llotd, et al., Am. J. Hypertens., 5, No. 7, 459-464 (1992).

    PubMed  CAS  Google Scholar 

  11. H. Frank and E. Kirberger, Biochem. Zh., 320, No. 4, 359-367 (1950).

    CAS  Google Scholar 

  12. E. Hagstrom, P. Hellman, E. Lundgren, et al., Diabetologia, 50, No. 2, 317-324 (2007).

    Article  PubMed  CAS  Google Scholar 

  13. J. Levy, Endocrine, 10, No. 1, 1-6 (1999).

    Article  PubMed  CAS  Google Scholar 

  14. M. F. McCarty, Med. Hypotheses, 66, No. 4, 824-831 (2006).

    Article  PubMed  CAS  Google Scholar 

  15. Zhe-hui Zhou, Li-ying Zhuang, and Ya-jun Song, Clin. J. N. Drugs Clin. Rem., 21, No. 8, 491-492 (2002).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S. S. Butakova.

Additional information

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 152, No. 11, pp. 484-490, November, 2011

Rights and permissions

Reprints and permissions

About this article

Cite this article

Butakova, S.S., Nozdrachev, A.D. Calcium Channel Blockers Inhibit the Hyperglycemic Effect of Calcitonin. Bull Exp Biol Med 152, 553–559 (2012). https://doi.org/10.1007/s10517-012-1573-3

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-012-1573-3

Key Words

Navigation